期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Perioperative Care in Patients with Ehlers Danlos Syndromes
1
作者 Pradeep Chopra Linda Bluestein 《Open Journal of Anesthesiology》 2020年第1期13-29,共17页
Background: There is an increasing recognition of patients with Ehlers Danlos Syndromes. The laxity of the ligaments and the weakness of the connective tissue has resulted in increasing number of patients requiring su... Background: There is an increasing recognition of patients with Ehlers Danlos Syndromes. The laxity of the ligaments and the weakness of the connective tissue has resulted in increasing number of patients requiring surgical intervention. Ehlers Danlos Syndromes are not about hypermobile joints only, they are associated with multiple co-existing conditions such as Chiari malformation, Tethered Cord Syndrome, spinal instability, abdominal pain, Dysautonomia and Mast Cell Activation Syndrome. The combined incidence of Ehlers Danlos Syndromes is 1 in 5000 people. Most experts believe that the actual incidence is much higher. Many of these cases are under-diagnosed. Nevertheless, patients with Ehlers Danlos Syndromes, diagnosed or undiagnosed often require surgical intervention. This review article has been written to shed light on the need for special consideration during anesthesia. Objectives: Our objective was to conduct a review of anesthetic considerations in patients with Ehlers Danlos Syndromes. Study Design: We used a narrative review design. Methods: This review was done using searches of PubMed, MEDLINE/OVID, SCOPUS, and manual searches of the bibliographies of known primary and review articles from inception to 2019. Other data sources included hand searches of publications driven by manuscript authors. Search terms included concepts of “Ehlers Danlos Syndrome”, “EDS”, “pain”, “anesthesia”, “surgery” and combination of terms. Search method was not restricted to any one language. Results: Articles were screened by title, abstract, and full article review. They were then analyzed by specific clinical indications and appropriate data was presented based on critical analysis of those articles. Limitations: More studies about the effect of anesthetic techniques and Ehlers Danlos Syndromes are required. Conclusions: Patients with Ehlers Danlos Syndromes may present with an array of coexisting medical conditions such as Dysautonomia, Mast Cell Activation Syndrome, Chiari Malformation, Tethered Cord Syndrome, Craniocervical instability, Gastroparesis, altered sensitivity to local anesthetics. Anesthetic techniques need to be modified according to the presentation. Preoperatively, a note should be made of the joints that sublux most often, craniocervical instability. They are prone to temporomandibular joint subluxation, obstructive sleep apnea and tracheomalacia, spontaneous pneumothorax, POTS, MCAS, insensitivity to local anesthetics and coagulation disorders. Intraoperative considerations should include fiberoptic intubation, IV fluid loading for POTS, avoid drugs that release histamine, unpredictable response to opioids, precautions for gastroparesis. Patient should be positioned to avoid joint subluxation and over stretching nerves. Postoperative considerations include maintaining hemodynamic stability, avoid exacerbation of symptoms of MCAS, high suspicion of occult bleeding, high risk of post dural puncture headache in patients undergoing spinal procedure or neuroaxial block. 展开更多
关键词 Anesthesia Ehlers Danlos syndromeS pots MCAS Mast Cell Activation syndrome POSTURAL orthostatic tachycardia syndrome
下载PDF
儿童体位性心动过速综合征46例临床分析 被引量:2
2
作者 孙薇薇 《海南医学》 CAS 2012年第17期33-35,共3页
目的探讨儿童体位性心动过速综合征的临床特征。方法收集我院2007年1月至2010年10月收治的以直立不耐受症状就诊并确诊为POTS的患儿共46例,同时选取24例正常儿童作为健康对照组,对患儿病史进行采集,详细询问患儿主要症状病程、发病时间... 目的探讨儿童体位性心动过速综合征的临床特征。方法收集我院2007年1月至2010年10月收治的以直立不耐受症状就诊并确诊为POTS的患儿共46例,同时选取24例正常儿童作为健康对照组,对患儿病史进行采集,详细询问患儿主要症状病程、发病时间、诱因、伴发症状,询问患儿既往史、有无晕阙史等。对入组研究的所有儿童进行身高、体重、心率、平卧状态的血压测定,并对患儿进行直立试验以及HUT检查。结果 POTS患儿主要发作诱因包括体位改变、持久站立、精神紧张、运动、疲劳、感染以及月经期;主要症状包括晕厥、头晕、大汗、胸闷、心悸、恶心呕吐、头痛以及视物模糊等。POTS组与对照组各项基本资料比较差异无统计学意义(P>0.05)。POTS组患儿治疗后症状评分、直立心率以及心率差值较治疗前显著改善,差异有统计学意义(P<0.05)。结论 POTS患儿各项基本资料与正常儿童之间差异无统计学意义,常见症状为晕厥、头晕、大汗、胸闷,而β1受体阻滞剂联合生理盐水口服可有效地治疗体位性心动过速综合征。 展开更多
关键词 儿童 体位性心动过速综合征 直立心率
下载PDF
盐酸米多君治疗儿童体位性心动过速综合征时间-疗效分析 被引量:3
3
作者 邓文军 杨锦艳 +2 位作者 刘严玲 杜军保 金红芳 《中国实用儿科杂志》 CSCD 北大核心 2013年第4期274-276,共3页
目的分析盐酸米多君治疗体位性心动过速综合征(POTS)患儿的时间-疗效关系,以探讨盐酸米多君治疗POTS小儿的最佳用药周期。方法随访2005—2011年北京大学第一医院104例接受盐酸米多君治疗6个月的POTS患儿,依据治疗效果与用药时间的关系... 目的分析盐酸米多君治疗体位性心动过速综合征(POTS)患儿的时间-疗效关系,以探讨盐酸米多君治疗POTS小儿的最佳用药周期。方法随访2005—2011年北京大学第一医院104例接受盐酸米多君治疗6个月的POTS患儿,依据治疗效果与用药时间的关系进行卡方检验并绘制时间-疗效曲线。结果依据盐酸米多君治疗时间,其累计有效率分别为1个月19.23%,2个月48.08%,3个月69.23%,4个月73.08%,5个月74.04%,6个月75.96%。卡方检验统计显示盐酸米多君治疗疗程为1个月及2个月时,其累计有效率与治疗疗程为3个月时的累计有效率相比较,差异有统计学意义(P<0.05),而治疗疗程为4、5和6个月时其累计有效率与治疗疗程为3个月时的累计有效率相比较,其差异均无统计学意义(P>0.05)。结论盐酸米多君治疗POTS小儿满3个月才能达到其最佳疗效,延长治疗疗程至6个月并不能显著提高治疗效果。 展开更多
关键词 体位性心动过速综合征 盐酸米多君 时间-疗效曲线
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部